Associated Medical Conditions for Celiac Disease

๐Ÿ“น Explaining this page and it's appropriate use.
The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Overlap Percent Prevalance in Population Matches Bacteria in From Bacteria in To
Alzheimer's disease 18 % 10% 9 50 67
Autism 35.8 % 2% 24 110 67
Ulcerative colitis 31.3 % 0.1% 21 108 67
Allergies 16 % 30% 8 50 67
Schizophrenia 17.9 % 0.75% 12 93 67
Ankylosing spondylitis 31.3 % 7% 21 520 67
Mood Disorders 16.7 % 29.7% 1 6 67
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 25.4 % 0.86% 17 134 67
Psoriasis 13 % 3% 6 46 67
Obesity 25.4 % 42.4% 17 104 67
Multiple Sclerosis 19.4 % 0.5% 13 100 67
Osteoporosis 27.3 % 9.4% 6 22 67
Amyotrophic lateral sclerosis (ALS) Motor Neuron 18.6 % 0.005% 8 43 67
neuropsychiatric disorders (PANDAS, PANS) 33.3 % 0.1% 5 15 67
Obesity 21.8 % 42.4% 12 55 67
ME/CFS without IBS 15.4 % 0.4% 4 26 67
Multiple system atrophy (MSA) 23.8 % 0.005% 5 21 67
Metabolic Syndrome 57.1 % 21% 4 7 67
ME/CFS with IBS 15.8 % 2.8% 3 19 67
Liver Cirrhosis 46.3 % 0.27% 31 678 67
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 19.4 % 25% 13 76 67
Parkinson's Disease 14.9 % 1% 10 90 67
Chronic Kidney Disease 20 % 15% 7 35 67
Systemic Lupus Erythematosus 21.2 % 0.15% 14 66 67
Depression 16.4 % 8% 11 81 67
Irritable Bowel Syndrome 21 % 15% 13 62 67
IgA nephropathy (IgAN) 20.7 % 0.001% 6 29 67
Insomnia 40 % 30% 4 10 67
Hyperlipidemia (High Blood Fats) 24 % 33% 6 25 67
hypercholesterolemia (High Cholesterol) 11.1 % 12% 1 9 67
gallstone disease (gsd) 20 % 5% 3 15 67
Chronic Urticaria (Hives) 26.1 % 5% 6 23 67
Graves' disease 12.5 % 0.5% 1 8 67
Functional constipation / chronic idiopathic constipation 12.2 % 14% 5 41 67
Epilepsy 28 % 0.84% 7 25 67
Fibromyalgia 10.8 % 1.12% 4 37 67
Inflammatory Bowel Disease 19.7 % 1.3% 13 66 67
Type 1 Diabetes 19.2 % 0.19% 10 52 67
COVID-19 25 % 50% 9 36 67
Cerebral Palsy 35.3 % 0.2% 6 17 67
Colorectal Cancer 17.9 % 4.3% 12 296 67
Chronic Fatigue Syndrome 10.9 % 3% 6 55 67
Coronary artery disease 25 % 6.7% 4 16 67
Carcinoma 31.4 % 1% 16 51 67
Barrett esophagus cancer 18.8 % 7% 3 16 67
Asthma 25.9 % 8% 7 27 67
Bipolar Disorder 15.2 % 3% 5 33 67
Atherosclerosis 25.4 % 50% 17 524 67
Crohn's Disease 37.3 % 0.3% 25 141 67
Acne 26.3 % 47% 5 19 67
Generalized anxiety disorder 21.4 % 2.7% 3 14 67
Small Intestinal Bacterial Overgrowth (SIBO) 31.3 % 52% 5 16 67
Brain Trauma 18.2 % 0.367% 4 22 67
Sjögren syndrome 31.7 % 1.2% 13 41 67
Stress / posttraumatic stress disorder 14.3 % 5.2% 8 56 67
Type 2 Diabetes 53.7 % 10.8% 36 267 67
ADHD 17 % 9.4% 8 47 67
Hashimoto's thyroiditis 21.4 % 0.35% 3 14 67

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.